ESR1 and breast cancer: Consequently, this study suggested that natural xenoestrogens, like naringenin, act as selective ER modulators by functioning on extranuclear Erα signaling pathways and providing critical information to develop tissue-specific E2 agonists and antagonists for breast cancer treatment [115].